IP Library Granted Patent US 9,302,997
Granted Patent B2
US 9,302,997 · App. 14/705,527 · Granted Apr 5, 2016

Copper-catalysed ligation of azides and acetylenes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,302,997
App. No.
14/705,527
Granted
Apr 5, 2016
Kind
B2
Abstract

A copper catalyzed click chemistry ligation process is employed to bind azides and terminal acetylenes to provide 1,4-disubstituted 1,2,3-triazole triazoles. The process comprises contacting a solution of an organic azide and a terminal alkyne with a source of catalytic Cu(I) ion to form a 1,4-disubstituted 1,2,3-triazole, wherein the source of Cu(I) ion comprises Cu(II) and a metal capable of reducing Cu(II) to Cu(I). In some embodiments, the metal capable of reducing Cu(II) to Cu(I) is selected from the group consisting of Al, Be, Co, Cr, Fe, Mg, Mn, Ni, and Zn.

Claims (18)

1. A copper catalyzed process for preparing a 1,4-disubstituted 1,2,3-triazole comprising:

contacting a solution of an organic azide and a terminal alkyne with a source of catalytic Cu(I) ion to form a 1,4-disubstituted 1,2,3-triazole, wherein the source of Cu(I) ion comprises Cu(II) and a metal capable of reducing Cu(II) to Cu(I).

2. The process of claim 1 , wherein the metal capable of reducing Cu(II) to Cu(I) is selected from the group consisting of Al, Be, Co, Cr, Fe, Mg, Mn, Ni, and Zn.

3. The process of claim 1 , wherein the metal capable of reducing Cu(II) to Cu(I) comprises Al.

4. The process of claim 1 , wherein the metal capable of reducing Cu(II) to Cu(I) comprises Be.

5. The process of claim 1 , wherein the metal capable of reducing Cu(II) to Cu(I) comprises Co.

6. The process of claim 1 , wherein the metal capable of reducing Cu(II) to Cu(I) comprises Cr.

7. The process of claim 1 , wherein the metal capable of reducing Cu(II) to Cu(I) comprises Fe.

8. The process of claim 1 , wherein the metal capable of reducing Cu(II) to Cu(I) comprises Mg.

9. The process of claim 1 , wherein the metal capable of reducing Cu(II) to Cu(I) comprises Mn.

10. The process of claim 1 , wherein the metal capable of reducing Cu(II) to Cu(I) comprises Ni.

11. The process of claim 1 , wherein the metal capable of reducing Cu(II) to Cu(I) comprises Zn.

12. The process of claim 1 , wherein the solution further comprises a ligand for Cu(I).

13. The process of claim 12 , wherein the ligand comprises one or more functional groups selected from the group consisting of a nitrile, an isonitrile, a primary amine, a secondary amine, a tertiary amine, a nitrogen bearing heterocycle, a carboxylate, a halide, an alcohol, a thiol, a sulfide, a phosphine, and a phosphite.

14. The process of claim 12 , wherein the ligand comprises a polyvalent ligand.

15. The process of claim 1 , wherein the solution comprises at least one solvent selected from the group consisting of water, a nitrile, and an alcohol.

16. The process of claim 1 , wherein the solution comprises at least one solvent selected from the group consisting of acetonitrile, ethanol, and tert-butanol.

17. The process of claim 1 , wherein the solution is an aqueous solution.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2019
From: CEMPRA PHARMACEUTICALS, INC.
To: TETARD, INC.
Reel/Frame 050056/0731 →
CONFIRMATORY LICENSE Recorded Dec 21, 2017
From: SCRIPPS RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 044932/0278 →